Sermorelin is a 29-residue fragment, and confirming that a given lot actually matches that sequence — cleanly, at a documented purity level — is the difference between a usable research reagent and an unverified powder.
Reversed-phase HPLC
Reversed-phase high-performance liquid chromatography separates a synthesis batch by hydrophobicity, resolving the intended sermorelin chain from truncated fragments and other byproducts that commonly arise during solid-phase peptide synthesis of a chain this length. General interpretation of the resulting purity figure is covered in understanding HPLC purity.
Mass spectrometry for identity
A clean HPLC trace alone does not prove the dominant peak is sermorelin rather than a structurally similar byproduct — mass spectrometry confirms molecular identity independently, a distinction explained in HPLC vs. mass spectrometry.
Why it matters for a GHRH-fragment tool
Because sermorelin's research value rests on precisely reproducing the native GHRH(1-29) sequence detailed in its chemistry article, even minor sequence deviations can alter receptor-binding behavior in ways that would confound a study without the researcher ever knowing material was the source of the discrepancy.
Documentation to expect
A lot-specific certificate of analysis, ideally corroborated by independent third-party testing — see how to read a CoA and third-party testing explained.
Product page: Sermorelin research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.